<DOC>
	<DOC>NCT00138801</DOC>
	<brief_summary>The aim of this study is to compare parenteral ceftriaxone and oral doxycycline in the treatment of neuroborreliosis in a randomized controlled trial.</brief_summary>
	<brief_title>Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis</brief_title>
	<detailed_description />
	<mesh_term>Lyme Neuroborreliosis</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>Neurological symptoms and/or findings consistent with neuroborreliosis and at least one of the following fulfilled: Intrathecal production of borrelia antibodies; White cell count in cerebrospinal fluid (CSF) &gt; 5/mm3; Significant rise in borrelia antibodies in two serum samples collected from a patient with at least 3 weeks interval; Verified acrodermatitis chronica atrophicans. Allergy to the contents in the medication, or earlier type I reaction to penicillin. Treatment with cephalosporins, penicillin or tetracyclins during the last 14 days Pregnancy or breastfeeding Age &lt; 18 years</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2005</verification_date>
	<keyword>Neuroborreliosis</keyword>
</DOC>